Untitled

Abstract

Cancer vaccines, a unique approach to cancer therapy are the propitious tools in the hands of the clinical oncologist. Immunization with these specific cancer vaccines put forth an antitumor effect by captivating the host immune response, and has immense prospective for avoiding the inherent drug resistance that confines typical cancer management. Strategies to attain affirmative clinical consequences are entrusted better with the combination of these cancer vaccines with the most effectual immunotherapy agents. Advantages recline as they have exquisite specificity, low toxicity, and the prospective for a robust treatment outcome due to immunologic memory. A handful of propitious prophylactic vaccines are found to be more flourishing in cancer deterrence, still the progress of effective cancer vaccines demand for continued efforts, thoughtful clinical trials, and scientific progress for effective and long-term specific cancer vaccines.